Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1955 1
1958 1
1959 2
1960 2
1968 1
1970 1
1991 1
1994 1
1996 2
1999 1
2000 1
2002 1
2003 2
2004 1
2005 2
2007 1
2008 3
2009 9
2010 5
2011 7
2012 7
2013 3
2014 5
2015 7
2016 10
2017 14
2018 10
2019 9
2020 8
Text availability
Article attribute
Article type
Publication date

Search Results

112 results
Results by year
Filters applied: . Clear all
Page 1
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.
Andtbacka RH, Kaufman HL, Collichio F, Amatruda T, Senzer N, Chesney J, Delman KA, Spitler LE, Puzanov I, Agarwala SS, Milhem M, Cranmer L, Curti B, Lewis K, Ross M, Guthrie T, Linette GP, Daniels GA, Harrington K, Middleton MR, Miller WH Jr, Zager JS, Ye Y, Yao B, Li A, Doleman S, VanderWalde A, Gansert J, Coffin RS. Andtbacka RH, et al. Among authors: cranmer l. J Clin Oncol. 2015 Sep 1;33(25):2780-8. doi: 10.1200/JCO.2014.58.3377. Epub 2015 May 26. J Clin Oncol. 2015. PMID: 26014293 Clinical Trial.
Propranolol for the treatment of vascular sarcomas.
Wagner MJ, Cranmer LD, Loggers ET, Pollack SM. Wagner MJ, et al. Among authors: cranmer ld. J Exp Pharmacol. 2018 Sep 6;10:51-58. doi: 10.2147/JEP.S146211. eCollection 2018. J Exp Pharmacol. 2018. PMID: 30233257 Free PMC article. Review.
Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma.
Hamid O, Puzanov I, Dummer R, Schachter J, Daud A, Schadendorf D, Blank C, Cranmer LD, Robert C, Pavlick AC, Gonzalez R, Hodi FS, Ascierto PA, Salama AKS, Margolin KA, Gangadhar TC, Wei Z, Ebbinghaus S, Ibrahim N, Ribas A. Hamid O, et al. Among authors: cranmer ld. Eur J Cancer. 2017 Nov;86:37-45. doi: 10.1016/j.ejca.2017.07.022. Eur J Cancer. 2017. PMID: 28961465 Clinical Trial.
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial.
Ribas A, Puzanov I, Dummer R, Schadendorf D, Hamid O, Robert C, Hodi FS, Schachter J, Pavlick AC, Lewis KD, Cranmer LD, Blank CU, O'Day SJ, Ascierto PA, Salama AK, Margolin KA, Loquai C, Eigentler TK, Gangadhar TC, Carlino MS, Agarwala SS, Moschos SJ, Sosman JA, Goldinger SM, Shapira-Frommer R, Gonzalez R, Kirkwood JM, Wolchok JD, Eggermont A, Li XN, Zhou W, Zernhelt AM, Lis J, Ebbinghaus S, Kang SP, Daud A. Ribas A, et al. Among authors: cranmer ld. Lancet Oncol. 2015 Aug;16(8):908-18. doi: 10.1016/S1470-2045(15)00083-2. Epub 2015 Jun 23. Lancet Oncol. 2015. PMID: 26115796 Clinical Trial.
16S rRNA gene sequencing on a benchtop sequencer: accuracy for identification of clinically important bacteria.
Watts GS, Youens-Clark K, Slepian MJ, Wolk DM, Oshiro MM, Metzger GS, Dhingra D, Cranmer LD, Hurwitz BL. Watts GS, et al. Among authors: cranmer ld. J Appl Microbiol. 2017 Dec;123(6):1584-1596. doi: 10.1111/jam.13590. Epub 2017 Nov 7. J Appl Microbiol. 2017. PMID: 28940494 Free PMC article.
Response to PD1 inhibition in conventional chondrosarcoma.
Wagner MJ, Ricciotti RW, Mantilla J, Loggers ET, Pollack SM, Cranmer LD. Wagner MJ, et al. Among authors: cranmer ld. J Immunother Cancer. 2018 Sep 25;6(1):94. doi: 10.1186/s40425-018-0413-z. J Immunother Cancer. 2018. PMID: 30253794 Free PMC article.
Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial.
Andtbacka RH, Ross M, Puzanov I, Milhem M, Collichio F, Delman KA, Amatruda T, Zager JS, Cranmer L, Hsueh E, Chen L, Shilkrut M, Kaufman HL. Andtbacka RH, et al. Among authors: cranmer l. Ann Surg Oncol. 2016 Dec;23(13):4169-4177. doi: 10.1245/s10434-016-5286-0. Epub 2016 Jun 24. Ann Surg Oncol. 2016. PMID: 27342831 Free PMC article. Clinical Trial.
T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
Pollack SM, He Q, Yearley JH, Emerson R, Vignali M, Zhang Y, Redman MW, Baker KK, Cooper S, Donahue B, Loggers ET, Cranmer LD, Spraker MB, Seo YD, Pillarisetty VG, Ricciotti RW, Hoch BL, McClanahan TK, Murphy E, Blumenschein WM, Townson SM, Benzeno S, Riddell SR, Jones RL. Pollack SM, et al. Among authors: cranmer ld. Cancer. 2017 Sep 1;123(17):3291-3304. doi: 10.1002/cncr.30726. Epub 2017 May 2. Cancer. 2017. PMID: 28463396 Free PMC article.
Angiosarcoma treated successfully with anti-PD-1 therapy - a case report.
Sindhu S, Gimber LH, Cranmer L, McBride A, Kraft AS. Sindhu S, et al. Among authors: cranmer l. J Immunother Cancer. 2017 Jul 18;5(1):58. doi: 10.1186/s40425-017-0263-0. J Immunother Cancer. 2017. PMID: 28716069 Free PMC article.
Pediatric Dental Clinic-Associated Outbreak of Mycobacterium abscessus Infection.
Hatzenbuehler LA, Tobin-D'Angelo M, Drenzek C, Peralta G, Cranmer LC, Anderson EJ, Milla SS, Abramowicz S, Yi J, Hilinski J, Rajan R, Whitley MK, Gower V, Berkowitz F, Shapiro CA, Williams JK, Harmon P, Shane AL. Hatzenbuehler LA, et al. Among authors: cranmer lc. J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):e116-e122. doi: 10.1093/jpids/pix065. J Pediatric Infect Dis Soc. 2017. PMID: 28903524
112 results
Jump to page
Feedback